ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Gross profit

Nissui Pharmaceutical Co., Ltd. (E00971)

Market cap
P/E ratio
Nissui Pharmaceutical manufactures and sells diagnostic drugs, test reagents, and testing equipment to medical institutions and testing facilities.
SummaryFinancialsDividendsHistoryWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 20225,258+25.28%
Mar 31, 20214,197-26.69%
Mar 31, 20205,725-0.57%
Mar 31, 20195,758-1.62%
Mar 31, 20185,853-8.31%
Mar 31, 20176,384+3.49%
Mar 31, 20166,168+3.94%
Mar 31, 20155,934

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat